Chlorine Dioxide vs PHMB for Pools and Spas

ClO₂

Chlorine Dioxide

Oxidising chemistry; performance must be established under the intended conditions
Legionella claims require product-specific organism, matrix, concentration and contact-time evidence
Biofilm claims require a representative biofilm method and system conditions
Use only within the product's labelled pH and water-quality conditions
Use the product-specified residual measurement method

PHMB

PHMB (Polyhexamethylene Biguanide)

Eye and skin effects depend on product conditions and individual sensitivity
Temperature limits must be checked on the product label
Non-oxidising; any separate oxidation step is product-programme specific
Chemical compatibility must be checked before changing programmes
Precipitation risk depends on the formulation and water chemistry

Detailed Comparison

Detailed comparison of chlorine dioxide versus phmb
Feature	Chlorine Dioxide	PHMB
Oxidising Action	Oxidising Confirm the water-quality objective and labelled conditions	Non-oxidising Check whether the labelled programme specifies a separate oxidant
Biofilm Evidence	Product-specific Require a representative matrix, concentration, time and conditions	Product-specific Do not infer biofilm performance from planktonic tests
Legionella Evidence	Product-specific Require organism, matrix, concentration, contact time and temperature	Product-specific Apply the same evidence standard to PHMB
pH Range	Check label Supporting tests must match the operating range	Check label Supporting tests must match the operating range
Chemical Compatibility	Assess before use Review all treatment chemicals and wetted materials	Assess before use Review all treatment chemicals and transition steps
Water Chemistry	Measure and verify Monitor relevant residuals and by-products	Measure and verify Check formulation-specific precipitation risks
Cost per swimmer-day	Site-specific Compare the complete labelled programme	Site-specific Compare the complete labelled programme
Residual Measurement	Product method Use the specified validated method	Product method Use the specified validated method
GB BPR PT2 Status	Check the product Confirm supply status and labelled PT2 use	Check the product Active-substance status is not product authorisation

When to Choose Each

Choose Chlorine Dioxide When:

The labelled use covers the intended pool or spa application
Legionella evidence matches the organism, matrix, concentration, time and temperature
Any biofilm objective is supported by a representative product test
The monitoring plan covers residual, chlorite and chlorate
The specified measurement method can be operated reliably
Whole-programme cost has been assessed for the site

Consider PHMB When:

The specific PHMB label covers the intended pool or spa use
The evidence matrix matches the target organism and operating conditions
Compatibility is confirmed for all treatment chemicals and wetted materials
The existing validated PHMB programme meets the written control scheme
Water analysis and product documents support the formulation

Why Choose ChloroKlean Plus L20

If you're considering switching to chlorine dioxide, ChloroKlean Plus L20 is purpose-built for industrial and commercial applications.

Check the Labelled PT2 Use

Confirm the specific product's GB supply status and that its label covers the intended pool or spa use. No EU or Northern Ireland authorisation is claimed.

Validate the Treatment Programme

Assess transition, compatibility, concentration, contact time, water quality, monitoring and any separate oxidation requirement from product documents.

Request the Evidence Matrix

Product evidence should identify the target organism, matrix, concentration, contact time, temperature and test conditions. A standard name or general dose is not enough.

Regulatory and Scientific References

This comparison is informed by the following authoritative sources. Always refer to the latest published guidance.

HSE HSG282

Health and Safety Executive (HSE)

Control of legionella and other infectious agents in spa-pool systems

HSG282 sets out management guidance for Legionella and other risks in spa pools. It does not make a universal product comparison or guarantee control from a stated dose.

View source

PWTAG Guidance

Pool Water Treatment Advisory Group (PWTAG)

Swimming Pool Water Treatment and Quality Standards

PWTAG publishes pool-water operation and treatment guidance. Current guidance and the specific product label should be checked for the intended facility; the citation is not a product efficacy endorsement.

View source

EU BPR PT2

European Chemicals Agency (ECHA)

Biocidal Products Regulation - Product Type 2

EU BPR is a separate regime from Great Britain. Active-substance status is route- and product-type-specific and does not establish authorisation of a particular product. No ChloroKlean EU or Northern Ireland authorisation is claimed.

View source

WHO Guidelines

World Health Organization (WHO)

Guidelines for safe recreational water environments - Volume 2 (Swimming Pools and Similar Environments)

WHO provides general recreational-water risk-management context. It does not establish a product-specific comparison, concentration or control outcome.

View source

ECHA PHMB Dossier

European Chemicals Agency (ECHA)

PHMB Biocidal Active Substance Assessment Report

ECHA assessment material provides active-substance regulatory context. Check the applicable formulation, product authorisation or supply status and label rather than inferring product efficacy from an active-substance dossier.

View source

Frequently Asked Questions

Both require use under their product conditions and a validated operating programme. Chlorine dioxide forms no chloramines, but no blanket eye, skin or comfort claim follows from that. HSG282 sets spa-pool management duties rather than endorsing one chemistry.

Cloudiness can have several causes. Some PHMB formulations may be incompatible with particular treatment chemicals or water conditions, but this should be diagnosed from the product documents, water analysis and operating records rather than assumed. Do not mix treatment products or change programme without a documented transition assessment.

A switch requires a site- and product-specific assessment; it is not a universal yes. Confirm chemical compatibility, the existing formulation, removal or neutralisation steps, wetted materials, refill and commissioning requirements, and the new product's labelled concentration, contact time and monitoring. Request the applicable product documents before changing programme.

Do not infer Legionella control from the active ingredient name. For either chemistry, require evidence for the specific product that identifies the Legionella strain, spa-water matrix, concentration, contact time, temperature and test conditions, then apply the label and verify the written control scheme. HSG282 provides management guidance, not a product guarantee.

That depends on the complete labelled treatment programme and the site's water-quality objectives. Chlorine dioxide is an oxidant, but that fact does not prove that a separate treatment step is unnecessary or justify a general shock dose. Follow the specific product label and validate concentration, contact time and monitoring for the actual matrix and operating conditions.

Neither chemistry is universally the better choice. Compare products against the risk assessment, intended use, GB BPR status, label, bather load, temperature, water matrix, compatibility and monitoring capability. Any efficacy evidence should state the target organism, concentration, contact time and test conditions. HSG282 sets management expectations rather than endorsing one chemistry.

Assess a Product-Specific Change From PHMB

Ask whether the specific ChloroKlean product's GB supply status, labelled use, concentration, contact time and evidence matrix fit the pool or spa control scheme.